Gerresheimer (ETR:GXI) Given a €55.90 Price Target by JPMorgan Chase & Co. Analysts

JPMorgan Chase & Co. set a €55.90 ($65.00) price objective on Gerresheimer (ETR:GXI) in a report released on Wednesday, Borsen Zeitung reports. The firm currently has a sell rating on the stock.

A number of other analysts have also recently commented on the stock. HSBC lowered their price objective on shares of WPP from GBX 1,000 ($13.07) to GBX 970 ($12.67) and set a hold rating for the company in a research report on Thursday, July 4th. Goldman Sachs Group cut shares of Anaplan from a buy rating to a neutral rating and set a $53.20 price objective for the company. in a research report on Monday, July 1st. Credit Suisse Group restated a hold rating on shares of FactSet Research Systems in a research report on Monday, July 8th. Berenberg Bank restated a sell rating and issued a GBX 600 ($7.84) price objective on shares of Great Portland Estates in a research report on Wednesday, May 22nd. Finally, Hauck & Aufhaeuser set a €120.00 ($139.53) target price on Hypoport and gave the stock a sell rating in a report on Thursday, April 11th. Three analysts have rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the company. Gerresheimer currently has a consensus rating of Hold and an average price target of €69.17 ($80.43).

GXI opened at €73.65 ($85.64) on Wednesday. The company has a debt-to-equity ratio of 68.19, a quick ratio of 0.51 and a current ratio of 0.78. Gerresheimer has a 12 month low of €51.10 ($59.42) and a 12 month high of €80.25 ($93.31). The company has a fifty day moving average price of €65.08. The company has a market cap of $2.31 billion and a PE ratio of 12.90.

About Gerresheimer

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Featured Article: What is a capital gains distribution?

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.